TRexBio prices IPO at $14 per share, expects $116.7M

๐ŸŒ Investing.com (Cyprus) —
TRexBio prices IPO at $14 per share, expects $116.7M

AI Summary

Biotechnology company TRexBio priced its initial public offering at $14 per share and expects to raise approximately $116.7 million. The IPO gives investors a new public-market entry point into the biotech sector.

Markets Deals Health TRexBio IPO biotechnology shares capital raising public markets

Read original source →